Reset
Showing 7 of 27 academic articles

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors

Safwaan H. Khan, Safwaan H. Khan, Yeonjoo Choi, Mysore Veena et al. • Frontiers in Immunology (2025)

Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of hematologic malignancies, achieving remarkable clinical success with FDA-approved therapies targeting CD19 and BCMA. However, the extension of these successe...

DOAJ Open Access (DOAJ) DOI: 10.3389/fimmu.2024.1489827

Lung cancer tumor immune microenvironment: analyzing immune escape mechanisms and exploring emerging therapeutic targets

Zhen Wang, Honglei Guo, Yanqi Song, Aidi Wang et al. • Frontiers in Immunology (2025)

Lung cancer is the most common malignant tumor in the world. Presently, there are still problems, including a high recurrence rate, resistance, and serious toxic side effects, even if conventional treatments like chemotherapy, radiotherapy,...

DOAJ Open Access (DOAJ) DOI: 10.3389/fimmu.2025.1597686

Integrative multiomics analysis of platelet-related genes unveils molecular subtypes and prognostic signatures in acute myeloid leukemia

Fangmin Zhong, Fangyi Yao, Zihao Wang, Bo Huang et al. • npj Precision Oncology (2025)

Abstract Acute myeloid leukemia (AML) remains challenging due to molecular heterogeneity and limited prognostic models integrating tumor microenvironment dynamics. While thrombocytopenia correlates with poor outcomes, the roles of platelet-...

DOAJ Open Access (DOAJ) DOI: 10.1038/s41698-025-01137-8

Immunogenic cell death-related macrophage gene model for prognostic prediction in glioblastoma

Yiming Mao, Ting Li, Wenqiang Lu, Chunhong Li et al. • Discover Oncology (2025)

Abstract Glioblastoma (GBM) is an extremely aggressive and diverse type of brain tumor that is associated with a poor prognosis. Immunogenic cell death (ICD) is a particular form of cellular demise that is closely linked to antineoplastic i...

DOAJ Open Access (DOAJ) DOI: 10.1007/s12672-025-03557-1